Comments

Chemours Stock Guidance

CCNYSE

Logo brought to you by Benzinga Data

Trade with Public

$11.78

-1.17-9.03%

At close: Dec 15, 4:00 PM EST

$11.76

-0.02-0.17%

After Hours: 7:21 PM EST

Overview News Earnings Options

Guidance

Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Chemours Stock Guidance | NYSE:CC | Benzinga

Chemours issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
11/06/2025	CC	Chemours	Q4	2025	—	—	—	$1.27B	$1.35B	$1.49B	Get Alert
11/06/2025	CC	Chemours	FY	2025	—	—	—	$5.70B	$5.80B	$5.88B	Get Alert
08/05/2025	CC	Chemours	Q3	2025	—	—	—	$1.52B	$1.55B	$1.57B	Get Alert
08/05/2025	CC	Chemours	FY	2025	—	—	—	$5.90B	$6.00B	$5.87B	Get Alert
04/30/2024	CC	Chemours	Q2	2024	—	—	—	$1.55B	$1.55B	$1.55B	Get Alert
02/28/2024	CC	Chemours	FY	2023	—	—	—	$6.00B	$6.00B	$6.02B	Get Alert
10/27/2023	CC	Chemours	FY	2023	$2.77	$3.00	$3.35	—	—	—	Get Alert
07/27/2023	CC	Chemours	FY	2023	$3.27	$3.60	$4.02	—	—	—	Get Alert
04/28/2023	CC	Chemours	FY	2023	$3.80	$4.29	—	—	—	—	Get Alert

FAQ

What is the most recent guidance for Chemours (CC)?

The most recent guidance for Chemours (CC) was reported on October 27, 2023 for the full year 2023. The company provided earnings per share guidance in the range of $2.77 to $3.00, compared to the estimated EPS of $3.35. Additionally, Chemours forecasted revenue between $0.00B and $0.00B for the quarter.

Browse guidance and forecast on all stocks.